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Introduction
Acute pancreatitis (AP) is a painful, life-threatening inflammatory disorder of the exocrine pancreas (Forsmark et al., 2016; Husain and Srinath, 2017) . AP has an incidence of 30-50 per 100 000 people per year worldwide, mainly caused by gallstones or alcohol misuse (Yadav and Lowenfels, 2013) . It is the third most common inpatient gastrointestinal diagnosis in the USA, accounting for more than 275 000 hospitalizations annually and an estimated annual cost over 2.6 billion dollars (Peery et al., 2015) . One out of five AP patients can develop a severe form with significantly increased mortality, prolonged hospital stay and consequent financial burden (Pandol et al., 2007; Peery et al., 2015) . Despite the substantial morbidity and mortality, treatments for pancreatitis are still largely supportive. Thus, there is a crucial need for new therapeutic approaches.
Over the last two decades, the sum of the mechanistic studies of AP suggest that the initial pancreatic injury starts within pancreatic acinar/ductal cells, and mitochondria play a central role in mediating disease severity and progression (Sutton et al., 2003; Hegyi et al., 2011; Mukherjee et al., 2016) . Pancreatitis-associated toxins, such as bile acids, cholecystokinin-8 (CCK) and palmitoleic acid cause mitochondrial depolarization, depletion of ATP and excessive ROS production and eventually activation of the necrotic cell death pathway (Petersen and Sutton, 2006; Mukherjee et al., 2016) . Distant organ dysfunction is primarily mediated by excessive inflammatory responses and is the leading cause of AP mortality (Pandol et al., 2007) . Phosphoinositide 3-kinases (PI3Ks) play a critical role in mediating inflammatory responses (Hawkins and Stephens, 2015) . During AP, PI3Ks, particularly the PI3Kγ isoform, regulate calcium signalling alteration, trypsinogen activation and NF-κB activation (Singh et al., 2001; Lupia et al., 2014) . These intra-pancreatic cellular and inflammatory events are key synergistic components that contribute to AP initiation and progression. Thus, the strategies that prevent both pancreatic cellular injury and excessive inflammatory responses could be potentially beneficial treatment of AP, which currently has no specific drug therapy.
We have recently reported that diosgenyl saponins isolated from from Disocorea zingiberensis C. H. Wright, particularly 26-O-β-D-glucopyranosyl-3β, 22α, 26-trihydroxy-25(R)-furosta-5-en-3-O-[α-L-rhamnopyranosyl-(1→4)]-β-Dglucopyranoside (Compound 1) protected against pancreatic acinar injury and three models of experimental AP (Zhang et al., 2016) , providing the impetus to further isolate and identify the most potent compound of the diosgenyl saponins for protection against AP. However, extracting diosgenyl saponins from D. zingiberensis C. H. Wright or other natural sources is not ideal for medicinal chemistry modifications, as the process of isolation is time-consuming and purification is challenging. The diosgenyl saponins extracted from D. zingiberensis C. H. Wright contain the core chemical structure known as diosgenin, which could potentially serve as a starting point for further modification. We previously showed diosgenin and diosgenyl esters have anti-inflammatory effects on xylene-induced ear oedema in mice (Huang et al., 2012) . Dihydrodiosgenin (Dydio), another parent aglycone of diosgenyl saponins, was synthesized by opening the spiroacetal ring of diosgenin (Del Fueyo et al., 2016) . Neither diosgenin nor its spiroacetal ring-opened analogue, Dydio, have yet been studied in pancreatitis. In this study, using mouse pancreatic acinar cells and three clinically representative models of AP, we sought to determine the pharmacological effects of diosgenin and its spiroacetal ring opened analogue on our models of pancreatitis.
First, we examined the effects of diosgenin and Dydio on Tauro-induced necrosis of pancreatic cells induced by sodium taurocholate (Tauro) and we found, compared with diosgenin, Dydio exerted more pronounced protective effects against Tauro-induced necrosis at all tested concentrations with no toxicity observed. For this reason, we focused further studies on Dydio and found that Dydio (at 100 μmol·L À1 ) prevented mitochondrial depolarization, ATP depletion, ROS production and activation of PI3Kγ/Akt in the pancreatic cells, as well as protecting against mitochondrial swelling in isolated mitochondria. Finally, we demonstrated that Dydio protected against three, in vivo, clinically representative, models of AP, through mitochondrial protection and PI3Kγ/Akt pathway inactivation. Furthermore, we showed that Dydio significantly improved pancreatitis-associated acute lung injury (ALI) primarily through preventing excessive inflammatory responses.
Methods

Animals
All animal care and experimental protocols were approved by the Ethics Committee of West China Hospital of Sichuan University (Approval number: 2014005B). All studies involving animals are reported in accordance with the ARRIVE guidelines [Kilkenny et al., 2010; McGrath and Lilley, 2015) . Specified pathogen free (SPF) male Balb/C mice (25-30 g; 6-8 weeks) and SPF male Wistar rats (250-300 g; 6-8 weeks) were purchased from Chengdu Dasuo Experimental Animal Co. Ltd (Chengdu, China). Four to five mice or rats were housed in a ventilated cage containing standard bedding. They were housed in a SPF animal facility under a 12 h light/dark cycle, 23 ± 2°C and humidity of 40-70%. Animals were fed standard laboratory chow, allowed access to water ad libitum and were acclimatized for at least 1 week prior to the experiments. Balb/C mice and Wistar rats have been widely used for experimental acute pancreatitis research (Awla et al., 2012; Chen et al., 2016) . Animals were assigned randomly to the experimental groups for all in vivo studies. Data collection and evaluation of all in vivo and in vitro experiments were carried out without knowledge of the treatments (blindly).
Pancreatic acinar cell preparation
Murine pancreatic acinar cells were prepared by enzymatic digestion with collagenase IV followed by mechanical disruption of the tissue, as described previously (Gerasimenko et al., 2013) . Briefly, the pancreas from a Balb/c mouse was removed and digested with collagenase IV (200 U·mL À1 ) for 19 min at 37°C. After this incubation with collagenase IV, cells were isolated by mechanical disruption of the tissue and filtered through a 100 μm cell strainer and then centrifuged at 110 × g for 2 min to obtain a cell pellet. The cells were then resuspended in the extracellular solution containing (in mmol·L À1 ): 140 NaCl, 4.7 KCl, 1.13 MgCl 2 , 1 CaCl 2 , 10 D-glucose, 10 HEPES (adjusted to pH 7.35 using NaOH). Each pancreas provided about 17.5 × 10 6 cells, resuspended in 8 mL. Cells were treated at room temperature and used within 4 h after the isolation.
Measurement of activation of the necrotic cell death pathway
Pancreatic acinar cells (2 × 10 6 cells, in 1 mL) were treated with Tauro (final concentration 5 mmol·L À1 ), with or without various concentrations of diosgenin or Dydio for 50 min, shaking at 110 × g at room temperature. After washing, cells were stained with Hoechst 33342 (50 μg·mL À1 ) for the nuclear stain and total cell counts. Cells were stained with propidium iodide (PI; 1 μmol·mL À1 ) to assess plasma membrane rupture as a marker of the activation of the necrotic cell death pathway (Cosker et al., 2014; Wen et al., 2015) . Images were recorded by fluorescence microscopy ZEISS AX10 imager A2/AX10 cam HRC (Jena GmbH, Germany). The total number of cells showing PI uptake was counted from each condition, with a minimum of 1000 cells counted, to provide the percentage (necrosis %) with five isolates per condition.
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (ΔΨm) was measured by using the JC-1-based mitochondrial membrane potential detection kit (Molecular Probes, USA) according to the manufacturer's instructions. At high membrane potential, JC-1 forms red-fluorescent J-aggregates, whereas green-fluorescent monomer exists at low potentials. The ratio between red and green fluorescence is used to measure changes in ΔΨm. A decrease in the ratio of red/green fluorescent intensity reflects mitochondrial depolarization (Xua et al., 2008 
Mitochondrial isolation
Mitochondria were isolated from mouse pancreas or liver using a differential centrifugation method as previously described (Fernandez et al., 2002; Biczo et al., 2018) . Briefly, mouse pancreas or liver were homogenized (80 mg tissue per mL) in mitochondrial isolation buffer containing (in mmol·L À1 ): 20 HEPES, 250 sucrose and 10 KCl, 1.5 MgCl 2 and 1 EGTA, pH 7.2-7.4. The homogenate was first centrifuged at 600× g for 5 min; the supernatant was then centrifuged at 1000× g for 10 min. The supernatant was saved and centrifuged at 7000× g for 10 min. The pellets were washed and centrifuged at 12 000× g for 10 min, then resuspended for mitochondrial swelling assay. 
Mitochondrial swelling assay
Induction of experimental AP in vivo
Tauro-induced AP (Tauro-AP) was induced in Wistar rats, as described previously (Perides et al., 2010) , by retrograde injection of the pancreatic duct with 3.5% Tauro (100 μL·min À1 by infusion pump). Rats were anaesthetised with 30 mg·kg À1 pentobarbital sodium. Buprenorphine (0.1 mg·kg À1 ) was given i.p. before the surgery and repeated 4 h later if necessary to relieve the pain. All animals recovered and were monitored for 4 h post-operatively. However, if the animals demonstrated excessive distress or pain, they were humanely killed. Twenty-four hours after the surgery, rats were humanely killed by overdose of pentobarbital and blood, pancreas and lung collected. Dydio (5 or 10 mg·kg À1 ) was i.p. administered 0.5 and 6 h after the surgery. Rats receiving only the laparotomy served as the control. Caerulein-induced AP (CER-AP) was induced in Balb/c mice by seven hourly i.p. injections of 50 μg·kg À1 caerulein (Lerch and Gorelick, 2013) , and the mice were killed 12 h after the first injection of caerulein. Dydio (5 or 10 mg·kg À1 )
was administered by i.p. injection at the second and seventh injections of CER.
Fatty acid ethyl ester-induced AP (FAEE-AP) was induced by two hourly i.p. injection of 200 mg·kg
À1 palmitoleic acid (POA) and 1.75 g·kg À1 ethanol (Huang, 2014) , and the mice were killed 24 h later. Dydio (5 or 10 mg·kg À1 ) was administered i.p. at 1 and 6 h after the first injection of POA and ethanol. Mice were humanely killed by cervical dislocation of the neck. The control mice were injected with equal volumes of normal saline according to the same schedules.
Serum amylase, lipase and IL-6 assays
Mixed arteriovenous blood was centrifuged for 15 min at 986 × g. Serum lipase and amylase were measured using a fully automatic biochemical analyser (Roche, Mannheim, Germany) following the manufacturer's instructions. Serum IL-6 levels were evaluated by IL-6 ELISA kit according to the manufacturer's protocols.
Myeloperoxidase activity measurement
Pancreatic and lung myeloperoxidase (MPO) activities were measured in homogenized pancreatic or lung tissue as described previously (Dawra et al., 2008) . Briefly, pancreatic and lung tissue samples were homogenized (60 mg per mL) in 100 mmol·L À1 phosphate buffer (pH 7.4) and centrifuged at 16 000× g for 15 min and the pellet resuspended in 100 mmol·L À1 PBS (pH 5.4). The suspension was subjected to three cycles of freezing and thawing, with sonication. After centrifugation, samples (20 μL containing 40 μg protein) of the supernatant was incubated in a reaction solution consisting of 100 mmol·L À1 sodium phosphate buffer, 0.5% HETAB and 2 mmol·L À1 TMB. The mixture was incubated at room temperature for 3 min, followed by the addition of hydrogen peroxide (0.01%; 50 μL). Absorbance was measured at 655 nm with a Synergy Mx multifunctional microplate reader, and MPO activity was calculated as the difference between absorbance at 0 and 3 min. Data were normalized to protein concentration, then normalized to AP group as 100% for each model, to control for unwanted sources of variation.
Activation of pancreatic trypsin
Samples of pancreas were homogenized (60 mg with 1 mL of homogenization buffer containing 5 mmol·L À1 3-morpholinopropanesulfonic acid, 1 mmol·L À1 Mg 2 SO 4 and 250 mmol·L À1 sucrose, pH 6.5) with a glass homogenizer, centrifuged at 1500× g for 5 min, and the supernatant was used for the assay. Trypsin activity was measured using BocGlu-Ala-Arg-MCA substrates, as described previously (Nathan et al., 2005) . Supernatant from the homogenized pancreas (3 mg protein per mL) was added to a 96-well plate (10 μL) and mixed with 280 μL assay buffer containing 50 mmol·L
À1
Tris-HCl (pH 8.0), 150 mmol·L À1 NaCl, 1 mmol·L À1 CaCl 2 and 0.1 mg·mL À1 BSA and 1.5 μL peptide substrate
Boc-Gln-Ala-Arg-MCA (10 mmol·L À1 ). Trypsin activity was measured by fluorometric assay. The fluorescence emitted at 440 nm in response to excitation at 380 nm was monitored. Data were normalized to protein concentration, then normalized to AP group as 100% for each model to control for unwanted sources of variation.
Western blot
Protein lysates from pancreatic tissue or isolated pancreatic acinar cells were prepared by homogenization in a RIPA containing proteinase and phosphatase inhibitors. Samples of lysates (20μg protein) were loaded on a 12% polyacrylamide gel. Primary antibodies PI3K p110-γ (1:500), Akt (1:1000), pAkt (1:1000) and β-actin (1:1000) were used. Images were detected by the enhanced chemiluminescence detection system (Millipore, USA). β-actin was used as a loading control. Data were collected and analysed from five independent samples.
Histology and immunohistochemistry
Fresh pancreatic and lung tissue were fixed in 4% paraformaldehyde overnight. Tissues were embedded in paraffin, cut into 5 μm sections and stained with haematoxylin and eosin (H&E). Pancreatic histopathological scores were evaluated blindly by two pathologists for oedema, inflammatory cell infiltration and necrosis, from 0 to 3 (Wildi et al., 2007, see Supporting Information Figure S1A and Table S1 ). Lung histopathological scores were evaluated for oedema and inflammatory cell infiltration, from 0 to 3 (Osman et al., 1998 , see Supporting Information Figure S1B and Table S2 ). For studies of toxicity, Samples of the pancreas, lung, heart, liver, spleen and kidney were examined by light microscopy after H&E staining. Pancreatic inflammatory cell infiltration was further evaluated by immunohistochemistry with F4/80, a marker for macrophages (Bombardo et al., 2018) . PI3K expression in vivo was measured at 12 h after the induction of CER-AP and 24 h after the induction of Tauro-AP and FAEE-AP. Primary antibodies used for immunohistochemistry were F4/80 (1:50) and PI3K p110γ (1:200). Antibody binding was visualized using peroxidase conjugated second antibody (1:200) (ZSGB-Bio Origene, Beijing, China) and 3,3 0 -diaminobenzidine solution. F4/80 or PI3Kγ-stained sections were analysed morphometry by an examiner blinded to sample identity. Ten randomly selected high-power fields (200×) were assessed per slide.
Data and statistical analysis
The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . The data are expressed as means ± SEM. The statistical analysis of results was performed using one-way ANOVA followed by Student's t-tests (GraphPad Prism 5.01; GraphPad Software Inc.). Post hoc tests were run only if F achieved P < 0.05, and there was no significant variance inhomogeneity. A value of P < 0.05 was considered statistically significant.
Materials
Dydio was obtained through diosgenin spiroacetal ring opening as described earlier (Ni et al., 1993; Del Fueyo et al., 2016) , and the structure of Dydio was verified by 13C NMR spectra. Diosgenin, sodium taurocholate hydrate (Tauro), caerulein, CCK, palmitoleic acid (POA), hexadecyl trimethyl ammonium bromide (HETAB) and tetramethyl benzidine (TMB) were purchased from Sigma-Aldrich (St. Louis, USA). Palmitoleic acid ethyl ester (POAEE) was from J&K Scientific (Beijing, China). The 740 Y-P was from ApexBio Technology (Houston, USA). Hoechst 33342, propidium iodide (PI), 2, 7-dichlorodi-hydrofluorescein diacetate (H2DCFDA) and JC-1 were from Molecular Probes (Eugene, USA). Collagenase IV was purchased from Worthington Biochemical Corporation (Lakewood, USA). Boc-Gln-Ala-Arg-MCA was obtained from Peptide (Ibaraki, Japan). Protease inhibitor cocktail tablets were from Roche Diagnostics (Mannheim, Germany). ATP determination kit and RIPA were obtained from Beyotime Biotech (Shanghai, China).Mouse IL-6 ELISA kit was from Raybiotech (Norcross, USA). Rat IL-6 ELISA kit was purchased from Neobioscience (Shenzhen, China). Antibody against PI3K p110-γ was obtained from Santa Cruz Biotechnology (Santa Cruz, USA); phospho-Akt (pAktSer473), Akt and β-actin were from Cell Signaling Technology (Danvers, USA); F4/80 was from Ascend Biotechnology (Guangzhou, China). Secondary antibodies were obtained from Jackson ImmunoResearch (West Grove, USA).
Nomenclature of targets and ligands
Key protein targets and ligands in this article are hyperlinked to corresponding entries in http://www.guidetopharmacology. org, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al., 2018) , and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/2018 (Alexander et al., 2017) .
Results
Diosgenin and Dydio concentrationdependently protect against Tauro-induced necrosis
To test whether diosgenin and Dydio prevented Tauroinduced necrosis, we used a well established assay to assess plasma membrane rupture by staining isolated pancreatic acinar cells with PI. Serial concentrations of diosgenin and Dydio, ranging from 1 to 400 μmol·L À1 were evaluated ( Figure 1A , B). Diosgenin and Dydio concentrationdependently reduced Tauro-induced necrosis, with concentrations of 100 μmol·L À1 showing the greatest inhibitory effect and no toxic effects observed with the high dose. At 400 μmol·L À1 , diosgenin increased the necrosis while Dydio was still protective. We therefore focused further studies on Dydio alone.
Dydio prevents mitochondrial dysfunction and activation of the PI3Kγ/Akt pathway
To understand how Dydio exerts its protective effects on isolated pancreatic acinar cells, we determined the effects of Dydio on mitochondrial functions, such as ΔΨm, ATP production and ROS generation. After treatment, we loaded the cells with JC-1 to measure the levels of ΔΨm. At high ΔΨm, JC-1 forms red-fluorescent 'J-aggregates', whereas greenfluorescent monomer exists at low ΔΨm. The ratio of red/green fluorescence densities is dependent only on the ΔΨm and used to measure changes in ΔΨm (Reers et al., 1991) . Incubation of pancreatic acinar cells with stimuli used to induce AP, such as Tauro, CCK and POAEE, caused a marked loss of ΔΨm, shown as decrease of the red/green fluorescence ratio. This loss was almost completely prevented by Dydio (100 μmol·L À1 ). (Figure 2A ). As ATP production through the electron transport chain is mediated by ΔΨm, the levels of ATP are directly correlated with the severity of pancreatic injury (Mukherjee et al., 2016) . In our experiments with isolated pancreatic acini, incubation with Tauro, CCK or POAEE caused a marked reduction of ATP levels after 30 min and addition of Dydio prevented this decrease of ATP levels ( Figure 2B ). The main source of cellular ROS is from mitochondria and is mediated by electron transport chain on the inner mitochondrial membrane (Booth et al., 2011) . Treatment with Tauro caused a sustained increase in cytosolic ROS and pretreatment with Dydio significantly decreased this increase ( Figure 2C ). Mitochondrial swelling is an important indicator of mitochondrial damage and mitochondrial permeability transition pore (mPTP) opening (Kristal et al., 2000) , and persistent opening of mPTP in response to mitochondrial Ca 2+ overload is an early event in experimental AP (Shalbueva et al., 2013; Mukherjee et al., 2016; Biczo et al., 2018) . We further evaluated the effect of Dydio on mitochondrial swelling using isolated pancreatic and liver mitochondria. We found that 1 μmol·L À1 Dydio decreased the rate of mitochondrial swelling in both pancreatic and liver mitochondria ( Figure 2D ), indicating that Dydio was protective via a direct action on the mitochondria. Overall, our data suggested that Dydio exerted its protective effect on pancreatic necrosis primarily by protecting mitochondria, most likely through a direct effect on the mitochondria. Dydio contains the core structure of steroid hormones, which bind to specific receptors to modulate downstream signal transduction, including the PI3K/Akt kinase pathway (Aquila et al., 2004) . Moreover, PI3Ks, particularly PI3Kγ, play a critical role in mediating inflammatory responses during AP (Hawkins and Stephens, 2015) . Hence, we examined the effects of Dydio on the activation of the PI3Kγ/Akt pathway in response to Tauro, in isolated pancreatic acinar cells. Incubation with Dydio for 30 min and 1 h decreased expression of PI3K p110γ and pAkt ( Figure 2E ). In addition, we used 740 Y-P, a PI3K activator (Williams and Doherty, 1999) and found Figure 2F ). These data further support the involvement of the PI3K/Akt pathway in the beneficial effects of Dydio. Taken together, our in vitro results suggest that Dydio exerted its protective effects by preventing two synergic pathophysiological events, pancreatic necrosis and excessive inflammatory responses.
Dydio protects against three experimental models of acute pancreatitis in vivo
Next, we sought to determine the effects of Dydio on models of AP in vivo. Before testing the effects of Dydio on these models of AP, we injected Dydio, i.p., at a high dose (20 mg·kg À1 ) in rats and mice to assess its toxicity. At this dose, Dydio did not cause any pathological changes in a range of tissues, including pancreas, lung, heart, liver, spleen and kidney (Supporting Information Figure S2 ). We also measured the levels of Dydio (10 mg·kg À1 ) present in the blood and pancreas at 1, 4 and 10 h after Dydio injection in one model of pancreatitis (as shown Figure 4A ). The highest Dydio levels were observed at 1 h after injection with 1.24 μmol·L
À1
in the blood and 87.7 μmol·g À1 in the pancreas. At 4 h, the levels of Dydio in the blood fell to about 50% and in the pancreas to about 20% of the 1h values and, at 10 h, the blood levels were about 60% and in the pancreas about 12% of the corresponding 1h values (Supporting Information Table S3 ). The effects of Dydio after induction of AP were further tested in three rodent models. First, we tested Dydio in a rat model of Tauro-induced AP, which is representative of acute biliary pancreatitis from ampullary gallstone obstruction (Lerch and Gorelick, 2013) . The half-life of diosgenin (the parent compound of Dydio) in normal rats was reported to be 5.7 h (Xu et al., 2009 ), so Dydio was given i.p., at 0.5 and 6 h after AP induction by Tauro ( Figure 3A) . As shown in Figure 3B , Dydio (5 or 10 mg·kg À1 ) reduced serum amylase, serum lipase activity, serum IL-6 level and pancreatic MPO activity, with the higher dose showing more pronounced reduction. These doses of Dydio also reduced pancreatic injury, Dydio protects against acute pancreatitis assessed as oedema, inflammatory infiltration and pancreatic necrosis using histological methods ( Figure 3C, D) . Hyperstimulation AP induced by caerulein (CER) is the most widely used experimental model (Lerch and Gorelick, 2013) . In our experiments, Dydio was given by i.p. injection at the second and seventh injections of CER ( Figure 4A ). Interestingly, Dydio (5 mg·kg À1 ) showed a clear reduction of the biochemical parameters, such as serum amylase and lipase, pancreatic trypsin activity and pancreatic MPO activity and a trend toward a decrease of serum IL-6. Dydio at the higher dose showed a trend toward a decrease of the biochemical parameters listed above ( Figure 4B ). Histological assays showed that Dydio at both doses markedly reduced pancreatic oedema, inflammatory infiltration and necrosis, with the higher dose showing greater reductions ( Figure 4C, D) . Furthermore, macrophage infiltration in the pancreas was decreased by treatment with Dydio (5 or 10 mg·kg À1 ) with the higher dose showing more effective reduction ( Figure 4E ). The third model of AP by i.p. co-administration of POA and ethanol (FAEE; Huang, 2014) . Dydio was administered by i.p. injection at 1 and 6 h after the first injection of POA and ethanol. Dydio (5 mg·kg À1 ) significantly reduced serum amylase and lipase, serum IL-6, pancreatic trypsin activity and MPO activity whereas the higher dose (10 mg·kg À1 ) only caused a trend toward a decrease of these biochemical parameters ( Figure 5B ). Interestingly, Dydio at both doses markedly reduced histological scores in pancreas, including oedema, inflammation and necrosis, with the pancreatic necrosis score approaching the control levels at both doses ( Figure 5C , D). Furthermore, Dydio at both doses decreased macrophage infiltration in the pancreas ( Figure 5E ).
Dydio prevents activation of the pancreatic PI3Kγ/Akt pathway in vivo
We next examined the effects of Dydio on the activation of pancreatic PI3Kγ/Akt in vivo by immunohistochemistry and immunoblotting. Consistent with our in vitro findings, in all three AP models, treatment with Dydio (5 and 10 mg·kg À1 )
down-regulated expression of PI3K p110γ and pAkt ( Figure 6 ).
Dydio protects against pancreatitis-associated acute lung injury (ALI)
An excessive inflammatory response is the key contributor to distant organ dysfunction (Deitch, 1992) , and we found that Dydio prevented pancreatic necrosis primarily through mitochondrial protection and could also attenuate inflammation by blocking the activation of PI3Kγ/Akt. Therefore, we hypothesized that Dydio could prevent excessive inflammatory responses and thus mitigate distant organ injury associated with pancreatitis. As ALI is one of the most frequent distant organ injuries associated with severe AP (Zhang et al., 2016) , we then examined the effects of Dydio on ALI in our models of AP. Treatment with Dydio (5 and 10 mg·kg À1 ) significantly reduced lung MPO in all the models of AP (Tauro, CER and FAEE) ( Figure 7A ). Further analysis of the Tauro-induced AP model showed that Dydio at both doses reduced lung histological scores and PI3K p110γ expression in with the higher dose showing greater effects. In summary, our in vivo data demonstrated that Dydio protected against pancreatic local damage and pancreatitis-associated ALI primarily through mitochondrial protection. The beneficial effects of Dydio on excessive inflammatory responses could be also through block of the activation of PI3Kγ/Akt.
Discussion
Diosgenin is a major effective ingredient of Dioscornin Tablets (SFDA Approval No. H20003743) and Dun-Ye-GuanXin-Ning Tablets (SFDA Approval No. Z32020309), preparations which have been used clinically for many years in China. In this study, we found that diosgenin and its spiroacetal ring opened analogue Dydio significantly decreased Tauro-induced activation of the necrotic cell death pathway in isolated pancreatic acinar cells. Compared with diosgenin, Dydio was more effective in protecting against necrosis at all tested concentrations with no toxicity observed. In mouse pancreatic acinar cells, Dydio prevented mitochondrial dysfunction, including the loss of ΔΨm, ATP depletion, ROS generation and mitochondrial swelling. A number of previous studies had demonstrated that diosgenin and its analogue exerted their protective effects in various disease models through preventing mitochondrial dysfunction, reducing oxidative stress and inhibiting the PI3K/Akt pathway (Turchan-Cholewo et al., 2006; Chen et al., 2011; Hsieh et al., 2013; Chen et al., 2015) . Consistent with these earlier reports, our in vitro data strongly suggested the protective effects of Dydio on pancreatic acinar cell necrosis were mediated primarily through mitochondrial protection, most likely through a direct effect on mitochondria. Dydio also suppressed inflammation by blocking activation of the PI3K/Akt pathway.
We were also able to show that therapeutic administration of Dydio (i.e. Dydio was given after disease induction) was beneficial in three clinically relevant models of AP. Clinically, pancreatic necrosis is one of the two determinants of mortality in patients with AP (Petrov et al., 2010) . Mitochondria are known as 'the point of no return' in the activation cascade of the cell death pathway (Kroemer et al., 2007) , and the major form of pancreatic acinar cell death is necrosis (Criddle et al., 2007) . The extent of necrosis is directly associated with disease severity in several models of experimental AP (Kaiser et al., 1995) . Notably, Dydio had a more pronounced effect on reducing pancreatic necrosis with the levels approaching the controls in FAEE-AP and close to the controls in Tauro-AP and CER-AP. Furthermore, Dydio treatment reduced serum IL-6 levels, macrophage infiltration in the pancreas and down-regulated PI3Kγ expression in the pancreas, from all three models of AP tested. PI3Kγ has been reported to be a crucial signalling molecule required for macrophage and neutrophil accumulation in inflammation (Hirsch et al., 2000) . These data suggest that the protective effect of Dydio on pancreatic local injury is primarily through preventing the mitochondria-mediated activation of the necrotic cell death pathway and blockade of the activation of the pancreatic PI3Kγ/Akt pathway. Such effects might synergise to mitigate excessive inflammatory responses at the initial site of the inflammation.
Finally, we showed that Dydio attenuated pancreatitisassociated distant organ injury, specifically ALI, as assessed by the reduction of thickness of the alveolar region, inflammatory infiltrate and lung MPO activity. It has been known for many years that injured pancreatic acinar cells produce, release and respond to cytokines, including TNF-α (Gukovskaya et al., 1997) . These inflammatory mediators trigger the recruitment of inflammatory cells to the pancreas and set off a cascade of inflammatory responses, leading to amplification of inflammatory mediators locally and systemically (Raraty et al., 2005; Vonlaufen et al., 2007) . Dydio downregulated expression of PI3K p110γ within the lung in Tauro-induced pancreatitis, an effect consistent with the beneficial effect of PI3Kγ inhibition in systemic inflammation and organ damage (Martin et al., 2010; Lupia et al., 2014) . Our data thus confirmed a role for PI3Kγ in mediating inflammatory responses during pancreatitis. Taken together, our in vivo data demonstrated that Dydio mitigated excessive inflammatory responses at the initial site of the inflammation and at the distant target organs.
Figure 6
Dydio prevents activation of pancreatic PI3Kγ/Akt in vivo. (A) PI3K p110γ levels in pancreas from indicated groups were analysed by immunohistochemistry. (B) Immunoblots for PI3K p110γ and pAkt in the pancreas from Tauro-AP (left), CER-AP (middle) or FAEE-AP (right) and the quantification (means ± SEM, n = 5). # P < 0.05, significantly different from control; *P < 0.05, significantly different from Tauro, CER or FAEE.
In summary, this study, for the first time, showed that Dydio, the parent aglycone of diosgenyl saponin, protected against pancreatic acinar cell injury in vitro and, in vivo, against three clinically relevant models of experimental AP and pancreatitis-associated distant organ injury, specifically ALI. These protective effects were mediated primarily through restoring mitochondrial function within the pancreas and suppressing PI3Kγ/Akt pathway at the initiation site and in the distant injured organ. This study provides an impetus for the further chemical modification of Dydio to discover novel compounds for treating AP. Future work will be also focused on identifying potential targets and understanding the precise mechanism(s) of action for diosgenin and its analogues. Dydio protects against acute pancreatitis assisted in the technical work. Y.S. and L.W. wrote the paper. W.H. and H.N. revised the paper. All authors approved the final edited version.
inflammation, and necrosis. (B) The arrows indicated lung oedema and inflammatory infiltration. Figure S2 Multi-organs H&E-stained sections of rats and mice in safety-study. Dydio (20 mg·kg À1 ) was i.p. administrated in rats or mice. Microscopic changes of the pancreas, lung, heart, liver, spleen, and kidney were examined by H&E staining.
Table S1
Criterial used for histopathological scoring of pancreatitis (Wildi et al., 2007) . Table S2 Criterial used for histopathological scoring of lung injury (Osman et al., 1998) . Table S3 Blood and pancreatic levels of Dydio after administering 10 mg·kg À1 in CER -AP (n = 3 for each group).
